ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
FRA:ILU - Deutsche Boerse Ag - US4523271090 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to ILU. ILU was compared to 15 industry peers in the Life Sciences Tools & Services industry. ILU has an average financial health and profitability rating. ILU has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
ILU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
Each year in the past 5 years ILU had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -19.39%, ILU is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
ILU's Return On Equity of -51.50% is on the low side compared to the rest of the industry. ILU is outperformed by 88.24% of its industry peers.
The Return On Invested Capital of ILU (9.56%) is better than 88.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.39% | ||
| ROE | -51.5% | ||
| ROIC | 9.56% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a Operating Margin (14.78%) which is comparable to the rest of the industry.
ILU's Operating Margin has declined in the last couple of years.
ILU's Gross Margin of 65.44% is amongst the best of the industry. ILU outperforms 100.00% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.78% | ||
| PM (TTM) | N/A | ||
| GM | 65.44% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILU is destroying value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
ILU has more shares outstanding than it did 5 years ago.
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
ILU has an Altman-Z score of 3.01. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ILU (3.01) is comparable to the rest of the industry.
The Debt to FCF ratio of ILU is 2.81, which is a good value as it means it would take ILU, 2.81 years of fcf income to pay off all of its debts.
ILU's Debt to FCF ratio of 2.81 is amongst the best of the industry. ILU outperforms 82.35% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that ILU is somewhat dependend on debt financing.
ILU has a worse Debt to Equity ratio (0.63) than 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.81 | ||
| Altman-Z | 3.01 |
ROIC/WACC0.88
WACC10.89%
2.3 Liquidity
ILU has a Current Ratio of 1.78. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
ILU's Current ratio of 1.78 is in line compared to the rest of the industry. ILU outperforms 58.82% of its industry peers.
A Quick Ratio of 1.42 indicates that ILU should not have too much problems paying its short term obligations.
ILU's Quick ratio of 1.42 is amongst the best of the industry. ILU outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 181.61%, which is quite impressive.
ILU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.93% yearly.
Looking at the last year, ILU shows a decrease in Revenue. The Revenue has decreased by -2.93% in the last year.
Measured over the past years, ILU shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)181.61%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%514.29%
Revenue 1Y (TTM)-2.93%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-1.6%
3.2 Future
ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.51% yearly.
Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 6.04% on average per year.
EPS Next Y88.3%
EPS Next 2Y46.41%
EPS Next 3Y34.19%
EPS Next 5Y26.51%
Revenue Next Year0.64%
Revenue Next 2Y2.81%
Revenue Next 3Y4.1%
Revenue Next 5Y6.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 34.19, the valuation of ILU can be described as expensive.
ILU's Price/Earnings is on the same level as the industry average.
ILU is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.18 indicates a rather expensive valuation of ILU.
70.59% of the companies in the same industry are more expensive than ILU, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ILU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.19 | ||
| Fwd PE | 18.18 |
4.2 Price Multiples
70.59% of the companies in the same industry are more expensive than ILU, based on the Enterprise Value to EBITDA ratio.
ILU's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ILU is cheaper than 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.74 | ||
| EV/EBITDA | 13.96 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 34.19% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y46.41%
EPS Next 3Y34.19%
5. Dividend
5.1 Amount
ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (3/7/2025, 7:00:00 PM)
77.26
-2.3 (-2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.43%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap12.24B
Analysts73.55
Price Target140.02 (81.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.56%
Min EPS beat(2)-7.76%
Max EPS beat(2)26.88%
EPS beat(4)2
Avg EPS beat(4)19.35%
Min EPS beat(4)-60.91%
Max EPS beat(4)119.22%
EPS beat(8)6
Avg EPS beat(8)340.29%
EPS beat(12)9
Avg EPS beat(12)230.8%
EPS beat(16)13
Avg EPS beat(16)182.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.91%
Revenue beat(8)4
Avg Revenue beat(8)-0.46%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)8
Avg Revenue beat(16)0.55%
PT rev (1m)-10.04%
PT rev (3m)-11.22%
EPS NQ rev (1m)-3.5%
EPS NQ rev (3m)-3.77%
EPS NY rev (1m)1.62%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)-2.12%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-3.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.19 | ||
| Fwd PE | 18.18 | ||
| P/S | 3.04 | ||
| P/FCF | 18.74 | ||
| P/OCF | 15.87 | ||
| P/B | 5.6 | ||
| P/tB | 13.77 | ||
| EV/EBITDA | 13.96 |
EPS(TTM)2.26
EY2.93%
EPS(NY)4.25
Fwd EY5.5%
FCF(TTM)4.12
FCFY5.34%
OCF(TTM)4.87
OCFY6.3%
SpS25.42
BVpS13.8
TBVpS5.61
PEG (NY)0.39
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.39% | ||
| ROE | -51.5% | ||
| ROCE | 13.58% | ||
| ROIC | 9.56% | ||
| ROICexc | 12.86% | ||
| ROICexgc | 21.37% | ||
| OM | 14.78% | ||
| PM (TTM) | N/A | ||
| GM | 65.44% | ||
| FCFM | 16.22% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.81 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 36.16% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 7.78 | ||
| Cash Conversion | 83.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.01 |
F-Score6
WACC10.89%
ROIC/WACC0.88
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)181.61%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%514.29%
EPS Next Y88.3%
EPS Next 2Y46.41%
EPS Next 3Y34.19%
EPS Next 5Y26.51%
Revenue 1Y (TTM)-2.93%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-1.6%
Revenue Next Year0.64%
Revenue Next 2Y2.81%
Revenue Next 3Y4.1%
Revenue Next 5Y6.04%
EBIT growth 1Y1504.35%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year39.47%
EBIT Next 3Y21.62%
EBIT Next 5Y19.88%
FCF growth 1Y151.42%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y75.1%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%